EAHAD/LinkedIn
Sep 5, 2025, 14:12
EAHAD Podcast: Reducing Pain and Distress in Children Receiving Emicizumab
EAHAD (The European Association for Haemophilia and Allied Disorders) posted on LinkedIn:
”New Podcast Alert! Join us for the latest “Meet the Author Interview” with Maj Friberg Birkedal, Chair of the EAHAD Nurses Committee, discussing how the Neria Guard infusion set may help reduce pain and distress for children receiving emicizumab. Drawing on real-world experience, she highlights why even small innovations can make a big difference in paediatric care.
Tune in now.”
Stay updated with Hemostasis Today.
-
Sep 15, 2026, 12:46Wolfgang Miesbach: Blood Centres as Health Weather Stations
-
Sep 15, 2026, 12:40Ronald F. Feinberg: Insulin Resistance May Be an Overlooked Cardiovascular Risk Factor
-
Sep 15, 2026, 12:33Seyed Mehrab Safdari: Factor VII Padua and the Limits of FVII Activity
-
Sep 15, 2026, 12:16Cedric Hermans: New Chinese Data Expand the Evidence for Hemophilia B Gene Therapy
-
Sep 15, 2026, 12:13Brianna Nobles: The Human Side of Rare, Voices From BDC2026
-
Sep 15, 2026, 12:04Ifeanyichukwu Ifechidere: When Coagulation Becomes Critical in Obstetrics
-
Sep 15, 2026, 11:55Yadira Torres MAS: Predicting Chronic Immune Thrombocytopenia in Children
-
Sep 15, 2026, 11:44Chokri Ben Lamine: Matching Anemia Treatment to the Myelofibrosis Patient
-
Sep 15, 2026, 11:17Adam Urato: How SSRIs May Affect Maternal and Fetal Serotonin